Clinical Trials in Texas

Showing 11081-11100 of 12,973 trials

Ondansetron and the QT Interval In Adult Emergency Department Patients

NCT01759420

The purpose of this study is to assess the use of the medication ondansetron (zofran) in the emergency department. There are studies of the ability of ondansetron to cause a prolongation in the QT interval (a certain measurement on an EKG) in anesthesia and cancer patients, but not on emergency department patients. This is an observational study where patients that are going to receive the anti-nausea medicine ondansetron in the emergency department will have an EKG performed every 2 minutes for 20 minutes to determine if the QT interval prolongs and returns to normal in that time period. Any serious outcomes will be reported. There is expected to be no adverse outcomes from this routinely used medication.

Ondansetron

C.R.Darnall Army Medical Center28 participantsStarted Dec 2012

Fort Hood, Texas, United States • Tacoma, Washington, United States

TERMINATEDPhase 255 miles

Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies

NCT00805467

The purpose of this new research study is to gain additional information about how safe and effective R935788 is over a longer period of time.

Rheumatoid Arthritis

AstraZeneca624 participantsStarted Aug 2008

La Jolla, California, United States • Palm Desert, California, United States • Palo Alto, California, United States +73 more locations

Ondansetron and the QT Interval In Adult Emergency Department Patients

Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies

Find Trials by Condition in Texas

Dose Range Finding Study of Fedovapagon in Men With Nocturia

A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma

Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension

Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism

Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors

A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV

Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia

An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer

A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa

A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder

Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.

AST-120 Used to Treat Mild Hepatic Encephalopathy

A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines

Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects

Non-traditional Cardiovascular Risk Factors and Atherosclerosis in Type 2 Diabetes

Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma

Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium